Analysis of the correlation between the blood concentration of infliximab and therapeutic effect for refractory ulcerative colitis

Analysis of the correlation between the blood concentration of infliximab and therapeutic effect for refractory ulcerative colitis - Analysis of the correlation between the blood concentration of IFX and therapeutic effect for refractory UC

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000006169

Enrollment

Registered

2011-08-13

Start date

2011-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ulcerative colitis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The objects are patients diagnosed with ulcerative colitis by the diagnostic criteria of Japanese Health, Labour and Welfare Ministry. The purpose and nature of this study are explained to each subject, and written informed comsent must be obtained.

Exclusion criteria

Exclusion criteria: Those patients who do not consent to this study.

Design outcomes

Primary

Measure	Time frame
Relation between the blood concentration of infliximab and clinical improvement assesed by endoscopic findings and clinical symptoms	—

Countries

Japan

Outcome results